Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
---|
02/12/2014 | EP2694545A1 BISPECIFIC BINDING MOLECULES BINDING TO Dll4 AND Ang2 |
02/12/2014 | EP2694544A2 Monoclonal antibodies against tissue factor pathway inhibitor (tfpi) |
02/12/2014 | EP2694543A2 Single chain antibodies for photosynthetic microorganisms and methods of use |
02/12/2014 | EP2694542A2 Herpes simplex virus |
02/12/2014 | EP2694541A1 Antibody product comprising n specific antibodies |
02/12/2014 | EP2694540A2 Use of an agent consisting of antibodies and/or insulin-like growth factor antagonists |
02/12/2014 | EP2694539A1 Polyclonal antibody compositions |
02/12/2014 | EP2694108A2 Methods for treating conditions associated with masp-2 dependent complement activation |
02/12/2014 | EP2694100A1 Formulations with reduced viscosity |
02/12/2014 | CN103582651A Monoclonal antibody capable of recognizing human papilloma virus (HPV) L2 protein, and method for measuring HPV-neutralizing antibody titer using same |
02/12/2014 | CN103582650A Method for preparing Fc-containing polypeptides having improved properties |
02/12/2014 | CN103582492A Factor XII inhibitors for the treatment of silent brain ischemia and ischemia of other organs |
02/12/2014 | CN103575889A Test strip and method for detecting vancomycin |
02/12/2014 | CN103571796A Chicken interleukin-10 monoclonal antibodies and preparation method and application thereof |
02/12/2014 | CN103570833A Human lactoferrin monoclonal antibody, and preparation method and application thereof |
02/12/2014 | CN103570832A Anti-Haemophilus parasuis porcine chimeric antibody, and construction method and application thereof |
02/12/2014 | CN103570831A Bovine-derived anti-staphylococcus aureus single-chain antibody as well as preparation method and application thereof |
02/12/2014 | CN103570830A Preparation method of anti-canine parvovirus protein VP2 specific IgY |
02/12/2014 | CN103570829A Method for extracting gamma-livetin (IgY) from yolk |
02/12/2014 | CN102936286B Anti-anthrax PA antigen monoclonal antibody and applications thereof |
02/12/2014 | CN102238962B Anti-ferroportin 1 monoclonal antibodies and uses thereof |
02/12/2014 | CN102197052B High affinity human antibodies to human IL-4 receptor |
02/12/2014 | CN101918442B Anti-VEGF antibodies |
02/12/2014 | CN101704892B Anti-uPAR humanized antibody, coding gene and application thereof |
02/12/2014 | CN101702906B Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins |
02/12/2014 | CN101309934B 修饰的伴侣蛋白10 Modified chaperonin 10 |
02/12/2014 | CN101147063B 5-fluoro-uracil immunoassay |
02/11/2014 | US8648182 Polynucleotides encoding antibodies to cytokine receptor zcytor17 |
02/11/2014 | US8648177 Lyophilization methods, compositions, and kits |
02/11/2014 | US8648176 Engineered proteins with high affinity for DOTA chelates |
02/11/2014 | US8648175 Stable pharmaceutical composition comprising erythropoietin |
02/11/2014 | US8648174 Ucp4 |
02/11/2014 | US8648173 Inhibition of tumor metastasis by anti neuropilin 2 antibodies |
02/11/2014 | US8648172 Anti-MUC1 α/β antibodies |
02/11/2014 | US8648171 Members of the FC receptor homolog gene family (FcRH1-3,6) related reagents and uses thereof |
02/11/2014 | US8648170 Peptide-presenting surfaces for long-term culture of pluripotent cells |
02/11/2014 | US8647887 Measuring G protein coupled receptor activation |
02/11/2014 | US8647831 Cobalamin assay |
02/11/2014 | US8647826 Nucleic acid and corresponding protein entitled 125P5C8 useful in treatment and detection of cancer |
02/11/2014 | US8647818 Molecular scaffolds for HIV-1 immunogens |
02/11/2014 | US8647630 Mite allergen |
02/11/2014 | US8647625 Anti-CD154 antibodies |
02/11/2014 | US8647624 Treatment of immune disorders with anti-CD70 antibody |
02/11/2014 | CA2634131C Protein formulations with reduced viscosity and uses thereof |
02/11/2014 | CA2623554C Methods and therapies for treating inflammatory conditions with exposed collagen |
02/11/2014 | CA2578341C Determining feline and canine probnp |
02/11/2014 | CA2564098C Solution phase biopanning method using engineered decoy proteins |
02/11/2014 | CA2529496C Anti-cd74 immunoconjugates and methods |
02/11/2014 | CA2471432C Nonhuman model animal lacking the ability to control lymphocyte migration |
02/11/2014 | CA2452946C Detection and diagnosis of transmissible spongiform encephalopathies |
02/11/2014 | CA2421751C Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom |
02/11/2014 | CA2387184C Cell-permeable peptide inhibitors of the jnk signal transduction pathway |
02/06/2014 | WO2014022853A1 Complex chromosome engineering for production of human antibodies in transgenic animals |
02/06/2014 | WO2014022758A1 Single agent anti-pd-l1 and pd-l2 dual binding antibodies and methods of use |
02/06/2014 | WO2014022679A2 Anti-etbr antibodies and immunoconjugates |
02/06/2014 | WO2014022592A1 Antibodies or fusion proteins multimerized via cysteine mutation and a mu tailpiece |
02/06/2014 | WO2014022540A1 Multivalent antigen-binding proteins |
02/06/2014 | WO2014021693A2 Novel monoclonal antibody which is specifically bound to tm4sf5 protein and use thereof |
02/06/2014 | WO2014021339A1 Monoclonal antibody against human midkine |
02/06/2014 | WO2014020922A1 Antibody and functional fragment thereof capable of treating diseases associated with hematopoietic stem cell transplantation such as graft-versus-host disease, and pharmaceutical composition comprising same |
02/06/2014 | WO2014020331A1 Therapeutic and diagnostic target |
02/06/2014 | WO2014020184A1 Means for treating heart disease |
02/06/2014 | WO2014020140A1 Use of transferrin receptor antagonist for the treatment of thalassemia |
02/06/2014 | WO2014020139A1 Method of generating antibodies |
02/06/2014 | WO2014020062A1 Novel anti-plasmodium parasite antibodies |
02/06/2014 | WO2014019727A1 Anti-fcrn antibodies |
02/06/2014 | WO2014019644A1 Selective measurement of active human protease coagulation factors |
02/06/2014 | WO2013166594A8 Heteromultimer constructs of immunoglobulin heavy chains with mutations in the fc domain |
02/06/2014 | WO2013004076A8 Agr2 blocking antibody and use thereof |
02/06/2014 | US20140041068 Methods of Modifying Eukaryotic Cells |
02/06/2014 | US20140039165 Anti-nr10 antibody and use thereof |
02/06/2014 | US20140039164 Therapeutic human anti-il-1r1 monoclonal antibody |
02/06/2014 | US20140039163 Cholesterol-dependent cytolysin variant and use thereof in dds |
02/06/2014 | US20140039162 Displaying native human IgE neutralizing FceRla-contacting IgE B-cell epitopes by constraining super beta(b)-strands and cystine knots on thermostable protein scaffold |
02/06/2014 | US20140039161 METHOD FOR EXTRACTING IgY (r-LIVETIN) FROM EGG YOLK |
02/06/2014 | US20140039155 Amyloid-beta peptide crystal structure |
02/06/2014 | US20140038842 Cell surface display using pdz domains |
02/06/2014 | US20140038287 Fc Receptor-Binding Polypeptides with Modified Effector Functions |
02/06/2014 | US20140038234 Expression System With Sar Element From IFNalpha2 |
02/06/2014 | US20140038210 ANTI-HUMAN IgG1 ANTIBODY |
02/06/2014 | US20140037717 Detection of Mutations in a Gene Associated with Resistance to Viral Infection, OAS1 |
02/06/2014 | US20140037667 Rapid selection method for hiv gp-120 variants |
02/06/2014 | US20140037664 Protein for use as a medicament |
02/06/2014 | US20140037651 Depleted anti-staphylococcal enterotoxins polyclonal antibodies, preparation and uses thereof |
02/06/2014 | US20140037650 Compositions and methods related to antibodies to staphylococcal proteins isda or isdb |
02/06/2014 | US20140037648 Antibodies that neutralize rsv, mpv and pvm and uses thereof |
02/06/2014 | US20140037646 Mmp8 inactivating antigen binding proteins |
02/06/2014 | US20140037643 Anti-notch2 nrr antibodies |
02/06/2014 | US20140037641 Peptide and Conjugate Vaccines for Fungal Infections |
02/06/2014 | US20140037639 LINGO Binding Molecules and Pharmaceutical Use Thereof |
02/06/2014 | US20140037638 Compositions and methods for treating amyloid plaque associated symptoms |
02/06/2014 | US20140037637 Mitigating tissue damage and fibrosis via latent transforming growth factor beta binding protein (ltbp4) |
02/06/2014 | US20140037636 Anti-cd98 antibody processes |
02/06/2014 | US20140037635 Methods of treatment using il-17e antagonists |
02/06/2014 | US20140037634 Regulatory t cell mediator proteins and uses thereof |
02/06/2014 | US20140037632 Multi-specific antigen-binding molecules and uses thereof |
02/06/2014 | US20140037631 Antigen binding formats for use in therapeutic treatments or diagnostic assays |
02/06/2014 | US20140037629 Humanized single-chain antibody against beta 3 integrin for the treatment and prevention of metastasis |
02/06/2014 | US20140037628 Anti-epidermal growth factor receptor variant iii chimeric antigen receptors and use of same for the treatment of cancer |
02/06/2014 | US20140037624 Anti-fgfr4 antibodies and methods of use |